Mereo BioPharma Group plc
MREO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001719714
No open-market purchases or sales by Mereo BioPharma Group plc insiders were filed in the last 90 days; 60 institutions reported holding it in 13F filings for Q2 2026, worth $18.0M in total; no superinvestor holds it.
Q3 2024 vs. Q2 2024
How the institutions holding Mereo BioPharma Group plc changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 79 | 1 | 77 | −1 |
| Shares | 100.5M | 16.8K | 105.8M | +5.25M (+5.2%) |
| Value | $361.9M | $60.5K | $434.8M | +$72.9M (+20.2%) |
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (11)
Institutions that held Mereo BioPharma Group plc at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| HealthInvest Partners AB | 200,000 | $822.0K | 0.39% |
| Hudson Bay Capital Management LP | 175,000 | $719.3K | 0.00% |
| Gsa Capital Partners LLP | 67,069 | $276.0K | 0.02% |
| State Street Corp | 47,561 | $195.5K | 0.00% |
| Ameriprise Financial Inc | 32,814 | $134.9K | 0.00% |
| BlackRock, Inc. | 14,321 | $58.9K | 0.00% |
| Graham Capital Management, L.P. | 12,699 | $52.2K | 0.00% |
| GPS Wealth Strategies Group, LLC | 1,500 | $6.17K | 0.00% |
| Tower Research Capital LLC (TRC) | 645 | $2.65K | 0.00% |
| Cranbrook Wealth Management, LLC | 60 | $247 | 0.00% |
| GeoWealth Management, LLC | 14 | $58 | 0.00% |
Sold out (12)
Institutions that held Mereo BioPharma Group plc at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Cantor Fitzgerald, L. P. | 275,000 | $990.0K |
| Suvretta Capital Management, LLC | 75,000 | $270.0K |
| Standard Life Aberdeen plc | 73,168 | $263.4K |
| Virtu Financial LLC | 14,152 | $51.0K |
| Two Sigma Securities, LLC | 13,926 | $50.1K |
| Adviser Investments LLC | 12,550 | $45.2K |
| Newbridge Financial Services Group, Inc. | 11,700 | $42.1K |
| The PNC Financial Services Group, Inc. | 4,524 | $16.3K |
| Quadrant Capital Group LLC | 398 | $1.43K |
| Plante Moran Financial Advisors, LLC | 48 | $173 |
| Royal Bank of Canada | 28 | $0 |
| Ariadne Wealth Management, LP | 3,499 | – |
Not filed for Q3 2024 yet (1)
Institutions that held Mereo BioPharma Group plc at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 16,792 | $60.5K |